Transcriptomic analysis of blood samples collected from SFTS patients

To investigate the mechanisms that contribute to the pathogenesis resulting from SFTSV infection, transcriptomic analysis was performed with blood samples collected from SFTS patients. Patients were divided into three groups based on their clinical status, namely “Recover”: SFTS patients during convalescence who have recovered from acute virus infection (n=19); “Acute. Recover”: SFTS patients during acute virus infection and who eventually recovered from the disease (n=22); and “Acute. Deceased”: SFTS patients during acute virus infection and who eventually died of SFTSV infection (n=17). The group of healthy control is composed by donors who have not experienced SFTSV infection (n=23)